FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085995544> ?p ?o ?g. }

• W2085995544 endingPage "356" @default.
• W2085995544 startingPage "350" @default.
• W2085995544 abstract "Clinical and experimental studies have been conducted to improve the survival of venous flaps. As a result of these studies, although various survival mechanisms were raised, none obtained satisfactory information. Venous stasis, and the resultant venous thrombosis, is a factor that decreases the survival of venous flaps. In this study, we evaluated the effects of two antiinflammatory agents, etodolac and etofenamate, on the survival of unipedicled venous flaps. In this study, 35 male New Zealand white rabbits (3,500–4,000 g) (70 ears) were used. Perichondrocutaneous flaps, 3 × 4.5 cm in size, were designed and raised, keeping the central veins intact in the middle of venous flap. Central arteries and nerves were ligated and transected both proximally and distally, to prepare unipedicled venous flaps. A silicone sheet was placed between the cartilage tissue and flap, to prevent blood flow and revascularization beneath. The subjects were divided into seven groups, consisting of five rabbits (10 ears). In the negative control group (group I), the single vascular pedicle of venous flaps, central veins were ligated and flaps sutured into their own place as the composite graft. In the positive control group (group II), after venous flaps were prepared, normal saline, 0.2 mL, was given subcutaneously. In the first of five experimental groups (group III), unfractionated heparin (100 U/day) was given subcutaneously. In the second experimental group (group IV), etodolac (5 mg/kg/day) was given subcutaneously. In the third experimental group (group V), etophenamate (5 mg/kg/day) was given orally through a feeding tube. In the fourth experimental group (group VI), parnaparin (5 anti-Xa U/kg/day) was given subcutaneously. In the fifth experimental group (group VII), nadroparin (5 anti-Xa U/kg/day) was given subcutaneously, about 7 days postoperatively. At the eighth postoperative day, surviving areas of venous flaps were measured, and the results were evaluated by Kruskal-Wallis ANOVA and Mann-Whitney U-test (P < 0.05). Biopsies were also taken from the flaps for histological evaluation of border of necrotic tissue. Surviving areas of unipedicled venous flaps were larger in experimental groups than those in negative and positive control group (P < 0.05). However, comparison of the experimental groups demonstrated no statistically significant difference (P > 0.05). We concluded that all pharmacological agents used in the experimental groups succeeded in increasing the survival of unipedicled venous flaps. Survival of the unipedicled venous flap was higher in venous flaps than that of composite graft, clearly showing the importance of the venous pedicle. © 2001 Wiley-Liss Inc. MICROSURGERY 21:350--356, 2001" @default.
• W2085995544 created "2016-06-24" @default.
• W2085995544 creator A5011388919 @default.
• W2085995544 creator A5030525651 @default.
• W2085995544 creator A5052676215 @default.
• W2085995544 creator A5060962081 @default.
• W2085995544 creator A5063406890 @default.
• W2085995544 date "2001-01-01" @default.
• W2085995544 modified "2023-10-10" @default.
• W2085995544 title "Effects of some pharmacological agents on the survival of unipedicled venous flaps: an experimental study" @default.
• W2085995544 cites W1516203868 @default.
• W2085995544 cites W177245439 @default.
• W2085995544 cites W1841172109 @default.
• W2085995544 cites W1868679695 @default.
• W2085995544 cites W1964642045 @default.
• W2085995544 cites W1966642056 @default.
• W2085995544 cites W1966683381 @default.
• W2085995544 cites W1970499314 @default.
• W2085995544 cites W1970659291 @default.
• W2085995544 cites W1975011526 @default.
• W2085995544 cites W1976290559 @default.
• W2085995544 cites W1984548841 @default.
• W2085995544 cites W1985485198 @default.
• W2085995544 cites W1987789579 @default.
• W2085995544 cites W1994171470 @default.
• W2085995544 cites W1998332441 @default.
• W2085995544 cites W2005469656 @default.
• W2085995544 cites W2005666696 @default.
• W2085995544 cites W2007827330 @default.
• W2085995544 cites W2008412049 @default.
• W2085995544 cites W2008700395 @default.
• W2085995544 cites W2027437571 @default.
• W2085995544 cites W2030559462 @default.
• W2085995544 cites W2031942893 @default.
• W2085995544 cites W2039396916 @default.
• W2085995544 cites W2045716011 @default.
• W2085995544 cites W2054392208 @default.
• W2085995544 cites W2056902129 @default.
• W2085995544 cites W2062781438 @default.
• W2085995544 cites W2066984959 @default.
• W2085995544 cites W2078694824 @default.
• W2085995544 cites W2082802426 @default.
• W2085995544 cites W2088724803 @default.
• W2085995544 cites W2114378084 @default.
• W2085995544 cites W2139727138 @default.
• W2085995544 cites W2156910938 @default.
• W2085995544 cites W2159438352 @default.
• W2085995544 cites W2160403105 @default.
• W2085995544 cites W2215237067 @default.
• W2085995544 cites W2242439670 @default.
• W2085995544 cites W2289219011 @default.
• W2085995544 cites W2314395292 @default.
• W2085995544 cites W2403279599 @default.
• W2085995544 cites W2409325070 @default.
• W2085995544 cites W2417924022 @default.
• W2085995544 cites W4252932277 @default.
• W2085995544 doi "https://doi.org/10.1002/micr.21801" @default.
• W2085995544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11757060" @default.
• W2085995544 hasPublicationYear "2001" @default.
• W2085995544 type Work @default.
• W2085995544 sameAs 2085995544 @default.
• W2085995544 citedByCount "5" @default.
• W2085995544 countsByYear W20859955442012 @default.
• W2085995544 crossrefType "journal-article" @default.
• W2085995544 hasAuthorship W2085995544A5011388919 @default.
• W2085995544 hasAuthorship W2085995544A5030525651 @default.
• W2085995544 hasAuthorship W2085995544A5052676215 @default.
• W2085995544 hasAuthorship W2085995544A5060962081 @default.
• W2085995544 hasAuthorship W2085995544A5063406890 @default.
• W2085995544 hasConcept C141071460 @default.
• W2085995544 hasConcept C2777202286 @default.
• W2085995544 hasConcept C2778736619 @default.
• W2085995544 hasConcept C2779851652 @default.
• W2085995544 hasConcept C2780011451 @default.
• W2085995544 hasConcept C2780868729 @default.
• W2085995544 hasConcept C42219234 @default.
• W2085995544 hasConcept C71924100 @default.
• W2085995544 hasConceptScore W2085995544C141071460 @default.
• W2085995544 hasConceptScore W2085995544C2777202286 @default.
• W2085995544 hasConceptScore W2085995544C2778736619 @default.
• W2085995544 hasConceptScore W2085995544C2779851652 @default.
• W2085995544 hasConceptScore W2085995544C2780011451 @default.
• W2085995544 hasConceptScore W2085995544C2780868729 @default.
• W2085995544 hasConceptScore W2085995544C42219234 @default.
• W2085995544 hasConceptScore W2085995544C71924100 @default.
• W2085995544 hasIssue "8" @default.
• W2085995544 hasLocation W20859955441 @default.
• W2085995544 hasLocation W20859955442 @default.
• W2085995544 hasOpenAccess W2085995544 @default.
• W2085995544 hasPrimaryLocation W20859955441 @default.
• W2085995544 hasRelatedWork W1498746036 @default.
• W2085995544 hasRelatedWork W1996292932 @default.
• W2085995544 hasRelatedWork W2085995544 @default.
• W2085995544 hasRelatedWork W2120112817 @default.
• W2085995544 hasRelatedWork W2371372815 @default.
• W2085995544 hasRelatedWork W2405361891 @default.
• W2085995544 hasRelatedWork W2792292372 @default.
• W2085995544 hasRelatedWork W2801779377 @default.

• next